These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 8487687)
21. Denaturing HPLC-identified novel FBN1 mutations, polymorphisms, and sequence variants in Marfan syndrome and related connective tissue disorders. Liu WO; Oefner PJ; Qian C; Odom RS; Francke U Genet Test; 1997-1998; 1(4):237-42. PubMed ID: 10464652 [TBL] [Abstract][Full Text] [Related]
22. Genetic disorders of collagen. Tsipouras P; Ramirez F J Med Genet; 1987 Jan; 24(1):2-8. PubMed ID: 3543367 [TBL] [Abstract][Full Text] [Related]
23. [Gene errors as a cause of rare and common connective tissue diseases]. Ala-Kokko L; Kuivaniemi H Duodecim; 1994; 110(7):731-9. PubMed ID: 8542828 [No Abstract] [Full Text] [Related]
24. Report on the Hypermobility Special Interest Group, British Society for Rheumatology meeting in Glasgow, April 1995. Morgan AW Br J Rheumatol; 1996 Apr; 35(4):392-3. PubMed ID: 8624648 [No Abstract] [Full Text] [Related]
26. Phenotypic heterogeneity of Marfan-like connective tissue disorders associated with mutations in the transforming growth factor-beta receptor genes. Akutsu K; Morisaki H; Takeshita S; Sakamoto S; Tamori Y; Yoshimuta T; Yokoyama N; Nonogi H; Ogino H; Morisaki T Circ J; 2007 Aug; 71(8):1305-9. PubMed ID: 17652900 [TBL] [Abstract][Full Text] [Related]
27. Fibrillin abnormalities and prognosis in Marfan syndrome and related disorders. Aoyama T; Francke U; Gasner C; Furthmayr H Am J Med Genet; 1995 Aug; 58(2):169-76. PubMed ID: 8533811 [TBL] [Abstract][Full Text] [Related]
28. [Congenital diseases of collagen. Clinical heterogeneity and molecular defects]. Hein R; Nerlich A; Müller P; Krieg T Internist (Berl); 1985 Jul; 26(7):420-8. PubMed ID: 3897110 [No Abstract] [Full Text] [Related]
29. Elastic fibres in health and disease. Kielty CM Expert Rev Mol Med; 2006 Aug; 8(19):1-23. PubMed ID: 16893474 [TBL] [Abstract][Full Text] [Related]
30. The molecular basis of Marfan syndrome. Maslen CL; Glanville RW DNA Cell Biol; 1993 Sep; 12(7):561-72. PubMed ID: 8397814 [TBL] [Abstract][Full Text] [Related]
36. The pathogenicity of the Pro1148Ala substitution in the FBN1 gene: causing or predisposing to Marfan syndrome and aortic aneurysm, or clinically innocent? Schrijver I; Liu W; Francke U Hum Genet; 1997 May; 99(5):607-11. PubMed ID: 9150726 [TBL] [Abstract][Full Text] [Related]
37. Marfan syndrome: light at the end of the tunnel? Tsipouras P Am J Hum Genet; 1990 Apr; 46(4):643-5. PubMed ID: 2316516 [No Abstract] [Full Text] [Related]
38. [Marfan syndrome. Current molecular data]. Boileau C; Coulon M; Junien C Arch Fr Pediatr; 1992 Dec; 49(10):941-3. PubMed ID: 1304168 [No Abstract] [Full Text] [Related]
39. The Gordon Wilson lecture. Mutations in type I procollagen genes. An explanation for brittle bones and a paradigm for other diseases of connective tissue. Prockop DJ Trans Am Clin Climatol Assoc; 1989; 100():70-80. PubMed ID: 3269104 [No Abstract] [Full Text] [Related]
40. Molecular heterogeneity: a clinical dilemma. Clinical heterogeneity: a molecular dilemma. Godfrey M Am J Hum Genet; 1993 Jul; 53(1):22-5. PubMed ID: 8317487 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]